One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The renal heading covers adults and children aged at least 3 months weighing more than 40 kg; it is not a small-child or neonatal schedule. The source also specifies additional doses both during and at the end of hemodialysis.
What to reconcile: Confirm population and local dialysis protocol. Do not silently change the source schedule.
Open this note and its source referencesGalway uses indexed eGFR and inpatient IV/PO ranges, whereas UCSF provides indication-specific oral CrCl schedules and specified dialysis assumptions. The printed UCSF headings leave exactly 30 unassigned. These protocols are not interchangeable.
What to reconcile: Resolve the printed boundary and match the indication, oral route and actual dialysis prescription.
Open this note and its source referencesExactly 30 is not assigned by the printed columns. Continuous-HD guidance rests on limited evidence and local expert judgment.
| CrCl, mL/min | Source-specific dose / instruction |
|---|---|
| >30 | 500 mg every 8 hours |
| 10-29 | 500 mg every 12 hours |
| <10 | 500 mg every 24 hours |
| CrCl, mL/min | Source-specific dose / instruction |
|---|---|
| >30 | 1 g every 8 hours |
| 10-29 | 1 g every 12 hours |
| <10 | 500 mg every 12 hours |
| Dialysis setting / indication | Source-specific schedule |
|---|---|
| IHD - enterococcal UTI | 500 mg initially, then each evening |
| IHD - selected severe-infection regimen | 500 mg every 12 hours |
| CVVHD - enterococcal UTI | 500 mg every 8 hours |
| CVVHD - selected severe-infection regimen | 1 g every 8 hours |
Oral doses for CrCl >30 / 10-29 / <10 mL/min:
IHD: enterococcal UTI uses 500 mg initially, then every evening; the severe-infection regimen uses 500 mg every 12 hours. CVVHD: respectively 500 mg or 1 g every 8 hours. Continuous-HD recommendations rely on limited evidence and local expert judgment.
The displayed non-dialysis bands omit exactly 30; consult an adjudicated product-specific boundary rather than inferring it.
RDM30-010-amoxicillin-1 · Source locator: UCSF - amoxicillin; renal/dosing sections and stated qualifiers
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=amoxicillin&s1=RDM30-010-amoxicillin&h1=f931de0339fd35a46a995a59fd6634ba9ef679316cafb05cd4063af65ec0db88